CD44 is an independent prognostic factor in early-stage cervical cancer
- 22 April 1997
- journal article
- Published by Wiley in International Journal of Cancer
- Vol. 74 (2) , 185-188
- https://doi.org/10.1002/(sici)1097-0215(19970422)74:2<185::aid-ijc8>3.0.co;2-v
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Prognostic value of CD44 splice variants in human stage III cervical cancerEuropean Journal Of Cancer, 1995
- Splice Variants of CD44 in Human Cervical Cancer Stage IB to IIBGynecologic Oncology, 1995
- Serum CD44 splice variants in cervical cancer patientsCancer Letters, 1995
- Colorectal cancer prognosis and expression of exon-v6-containing CD44 proteinsThe Lancet, 1994
- CD44 splice variants: metastases meet lymphocytesImmunology Today, 1993
- Regulated expression of exon v6 containing isoforms of CD44 in man: downregulation during malignant transformation of tumors of squamocellular originThe Journal of cell biology, 1993
- Lymphocyte homing and clinical behavior of non-Hodgkin's lymphoma.Journal of Clinical Investigation, 1991
- ALTERNATIVE SPLICING IN THE CONTROL OF GENE EXPRESSIONAnnual Review of Genetics, 1989
- Nonparametric Estimation from Incomplete ObservationsJournal of the American Statistical Association, 1958